News

Additional funding strengthens a growing research environment in Örebro where PExA is used in multiple studies

PExA announces that the Company’s instrument and method are playing an increasingly clear role in the growing research environment at Örebro University and Region Örebro County, focused on occupational particle exposure and early biomarkers of lung effects.  Örebro University and Region Örebro County have been awarded SEK 2.4 million from Nyckelfonden 2026 for the RESPIMARK…

Read more

PExA highlights the potential for early detection of lung diseases at Life Science Day – presentation now available online

At Life Science Day in Gothenburg on March 4, Tomas Gustafsson, CEO of PExA AB, presented the company’s technology for collecting biological material from the small airways through analysis of particles in exhaled air. A recording of the presentation is now available online. PExA’s instrument enables non-invasive sampling from the smallest airways of the lung—an area where…

Read more

PExA Founder Interviewed in Sweden’s Largest Regional Newspaper Göteborgs-Posten – Focus on Early Detection of Lung Disease

Professor Anna-Carin Olin, founder of PExA and Professor of Occupational and Environmental Medicine at the University of Gothenburg, has been interviewed in the Swedish newspaper Göteborgs-Posten about how lung diseases may develop in the small airways long before they can be detected using current methods. “In Sweden, approximately 15 percent of all people who develop…

Read more

PExA’s transformation journey toward future diagnostics highlighted by MedTech Magazine

MedTech Magazine, Sweden’s only media outlet fully dedicated to medical technology, has recently published an in-depth feature on PExA. Under the headline “PExA on a transformation journey – aiming to bring lung cancer instrumentation to primary care”, the article highlights the company’s exhalation-based technology, which holds potential for future diagnostic applications in respiratory disease. The article…

Read more